Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online September 14, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0328v1
25/1/189    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Panepucci, R. A.
Right arrow Articles by Zago, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panepucci, R. A.
Right arrow Articles by Zago, M. A.
Submitted on May 30, 2006
Accepted on September 7, 2006

Stem Cell Genetics and Genomics

Higher Expression of Transcription Targets and Components of the NF-{kappa}B Pathway is a Distinctive Features of Umbilical Cord Blood CD34+ Precursors

Rodrigo A. Panepucci 1, Rodrigo T. Calado 1, Vanderson Rocha 2, Rodrigo Proto-Siqueira 1, Wilson A. Silva, Jr. 1, Marco A. Zago 1*

1 Center for Cell Therapy and Regional Blood Center, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo, Ribeirão Preto, Brazil
2 Bone Marrow Transplantation Unit, Hôpital Saint-Louis, Paris, France

* To whom correspondence should be addressed. E-mail: marazago{at}usp.br.


   Abstract

Delayed engraftment, better reconstitution of progenitors, higher thymic function, and a lower incidence of the graft versus host disease (GVHD) are characteristics associated with umbilical cord blood (UCB) transplants, when compared to bone marrow (BM). To understand the molecular mechanisms causing these intrinsic differences we analyzed the differentially expressed genes between BM and UCB HSPC. The expression of approximately 10.000 genes were compared by serial analysis of gene expression (SAGE) of magnetically sorted CD34+ cells from BM and UCB. Differential expression of selected genes was evaluated by real-time PCR on additional CD34+ samples from BM (n=22), UCB (n=9) and G-CSF mobilized peripheral blood (MPB, n=6). The overrepresentation of NF-{kappa}B pathway components and targets was found to be a major characteristic of UCB HSPC. Additional promoter analysis of 41 UCB overrepresented genes revealed a significantly higher number of NF-{kappa}B cis-regulatory elements (present in 22 genes), than expected by chance. Our results point to an important role of the NF-{kappa}B pathway on the molecular and functional differences observed between BM and UCB HSPC. Our study sets the basis for future studies and to potentially new strategies to stem cell graft manipulation, by specific NF-{kappa}B pathway modulation on stem cells, prior to transplant.

Key Words. hematopoiesis, stem cells, NF-kappa B, umbilical cord blood, bone marrow




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
P. R. Crisostomo, Y. Wang, T. A. Markel, M. Wang, T. Lahm, and D. R. Meldrum
Human mesenchymal stem cells stimulated by TNF-{alpha}, LPS, or hypoxia produce growth factors by an NF{kappa}B- but not JNK-dependent mechanism
Am J Physiol Cell Physiol, March 1, 2008; 294(3): C675 - C682.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2006 by AlphaMed Press.